• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

World J Clin Cases . Clinical features and risk factors of severely and critically ill patients with COVID-19

tetano

Editor, Senior Moderator
World J Clin Cases


. 2022 Jan 21;10(3):840-855.
doi: 10.12998/wjcc.v10.i3.840.
Clinical features and risk factors of severely and critically ill patients with COVID-19


Xin Chu[SUP] 1 [/SUP], Gui-Fang Zhang[SUP] 2 [/SUP], Yong-Ke Zheng[SUP] 3 [/SUP], Yi-Gang Zhong[SUP] 4 [/SUP], Li Wen[SUP] 5 [/SUP], Ping Zeng[SUP] 2 [/SUP], Chun-Yi Fu[SUP] 5 [/SUP], Xun-Liang Tong[SUP] 6 [/SUP], Yun-Fei Long[SUP] 7 [/SUP], Jing Li[SUP] 8 [/SUP], Ya-Lin Liu[SUP] 1 [/SUP], Zhi-Gang Chang[SUP] 1 [/SUP], Huan Xi[SUP] 9 [/SUP]



Affiliations

Abstract

Background: As of June 1, 2020, over 370000 coronavirus disease 2019 (COVID-19) deaths have been reported to the World Health Organization. However, the risk factors for patients with moderate-to-severe or severe-to-critical COVID-19 remain unclear.
Aim: To explore the characteristics and predictive markers of severely and critically ill patients with COVID-19.
Methods: A retrospective study was conducted at the B11 Zhongfaxincheng campus and E1-3 Guanggu campus of Tongji Hospital affiliated with Huazhong University of Science and Technology in Wuhan. Patients with COVID-19 admitted from 1[SUP]st[/SUP] February 2020 to 8[SUP]th[/SUP] March 2020 were enrolled and categorized into 3 groups: The moderate group, severe group and critically ill group. Epidemiological data, demographic data, clinical symptoms and outcomes, complications, laboratory tests and radiographic examinations were collected retrospectively from the hospital information system and then compared between groups.
Results: A total of 126 patients were enrolled. There were 59 in the moderate group, 49 in the severe group, and 18 in the critically ill group. Multivariate logistic regression analysis showed that age [odd ratio (OR) = 1.055, 95% (confidence interval) CI: 1.099-1.104], elevated neutrophil-to-lymphocyte ratios (OR = 4.019, 95%CI: 1.045-15.467) and elevated high-sensitivity cardiac troponin I (OR = 10.126, 95%CI: 1.088 -94.247) were high-risk factors.
Conclusion: The following indicators can help clinicians identify patients with severe COVID-19 at an early stage: age, an elevated neutrophil-to-lymphocyte ratio and high sensitivity cardiac troponin I.

Keywords: Amino-terminal pro-brain natriuretic peptide; Aspartate transaminase; COVID-19; Calcium; Creatinine; Critically ill; Risk factors; SARS-CoV-2.
 
Back
Top Bottom